PTAFR and melanoma: PAF and Ox-GPCs mediate their effects via binding to a seven-transmembrane-G-protein coupled receptor, the PAF-receptor (PAF-R), expressed on various immune and nonimmune cell types and cancer cells including melanoma [18–20].